Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells
Abstract Successful cell therapy for Parkinson’s disease (PD) requires large numbers of homogeneous ventral mesencephalic dopaminergic (vmDA) precursors. Enrichment of vmDA precursors via cell sorting is required to ensure high safety and efficacy of the cell therapy. Here, using LMX1A-eGFP knock-in...
Guardado en:
Autores principales: | Jeong-Eun Yoo, Dongjin R. Lee, Sanghyun Park, Hye-Rim Shin, Kun Gu Lee, Dae-Sung Kim, Mi-Young Jo, Jang-Hyeon Eom, Myung Soo Cho, Dong-Youn Hwang, Dong-Wook Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4503967311b2473da2382379507f5f03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease.
por: Sonya Carvalho Neto, et al.
Publicado: (2012) -
Altered Development of Mesencephalic Dopaminergic Neurons in SIDS: New Insights into Understanding Sudden Infant Death Pathogenesis
por: Anna Maria Lavezzi
Publicado: (2021) -
Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis.
por: Diogo Ribeiro, et al.
Publicado: (2011) -
TROPHOBLASTIC β1 – GLYCOPROTEIN SYNTHESIS IN SEROPOSITIVE PREGNANT WOMEN
por: R. N. Bogdanovich, et al.
Publicado: (2014) -
Interhemispheric transcallosal transchoroidal approach for resection of a mesencephalic lesion
por: Lucas Pires Augusto, et al.
Publicado: (2019)